ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9-27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)-An NCDB Analysis.
Saved in:
| Title: | ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9-27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)-An NCDB Analysis. |
|---|---|
| Authors: | Burkbauer L; Division of Endocrine and Oncologic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, 10th Floor PCAM South, Philadelphia, PA, 19104, USA., Goldbach MM; Division of Endocrine and Oncologic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, 10th Floor PCAM South, Philadelphia, PA, 19104, USA., Tchou JC; Division of Endocrine and Oncologic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, 10th Floor PCAM South, Philadelphia, PA, 19104, USA. Julia.Tchou@pennmedicine.upenn.edu. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2021 Dec; Vol. 28 (13), pp. 8663-8664. Date of Electronic Publication: 2021 Jul 24. |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1534-4681 |
|---|---|
| DOI: | 10.1245/s10434-021-10517-w |
